The Evolution of Lymphangioleiomyomatosis (LAM) Management: From Hormonal Manipulation to Targeted Inhibition of the mammalian target of rapamycin (mTOR) Pathway. Research, Society and Development, [S. l.], v. 14, n. 4, p. e4614448656, 2025. DOI: 10.33448/rsd-v14i4.48656. Disponível em: https://ojs34.rsdjournal.org/index.php/rsd/article/view/48656. Acesso em: 29 jun. 2025.